Hypertension is highly prevalent, but its pharmacological management has not been well evaluated in low- and middle-income countries (LMICs). This review examined the prescribing patterns of antihypertensives in LMICs. Data were extracted from a total of 26 studies spanning the time period 2000 to 2018. In 10 studies, calcium channel blockers (CCBs) were the most frequently prescribed medication for managing hypertension (range = 33% to 72%); in six studies, renin angiotensin system (RAS) blockers (range = 25% to 83%); in five studies, diuretics (range = 39% to 99%); and in five studies, β-blockers (BBs; range = 26% to 49%) were the most commonly prescribed antihypertensive medications. Prescribing sedatives and sublingual administration of captopril for controlling hypertension was also reported in 3 studies. Only 10 studies presented their findings in light of national or international guidelines. This review calls for further antihypertensive utilization and dispensation studies and a better understanding of clinician’s perception and practice of hypertension management guidelines in LMICs.
NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37-55.
2.
ShinHYKangHT.Recent trends in blood pressure according to economic status: Korean National Health and Nutrition Examination Survey from 2005 to 2015. Asia Pac J Public Health. 2018;30:266-275.
3.
SarkiAMNdukaCUStrangesSKandalaNBUthmanOA.Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1959.
4.
AlmasAEhtamamAKhanAH.Spectrum of antihypertensive therapy in South Asians at a tertiary care hospital in Pakistan. BMC Res Notes. 2011;4:318.
5.
OwolabiMOlowoyoPMirandaJJ, et al. Gaps in hypertension guidelines in low-and middle-income versus high-income countries: a systematic review. Hypertension. 2016;68:1328-1337.
6.
DattaS.Utilization study of antihypertensives in a South Indian tertiary care teaching hospital and adherence to standard treatment guidelines. J Basic Clin Pharm. 2016;8:33-37.
7.
OjjiDBMayosiBFrancisV, et al. Comparison of dual therapies for lowering blood pressure in black Africans. N Engl J Med. 2019;380:2429-2439.
8.
MoherDLiberatiATetzlaffJAltmanDG; PRISMA Group. Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89: 873-880.
9.
KramohEKN’goranYNAké-TraboulsiE, et al. Hypertension management in an outpatient clinic at the Institute of Cardiology of Abidjan (Ivory Coast). Arch Cardiovasc Dis. 2011;104:558-564.
10.
El MawardyROkbaA. Antihypertensive treatment and blood pressure control in patients with hypertension in daily clinical practice: a cross-sectional, multicenter, observational study in Egypt. Curr Med Res Opin. 2017;33:39-45.
11.
TiwariHKumarAKulkarniSK.Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45:117-120.
12.
MohdAHMatetiUVKonuruVParmarMYKunduruBR.A study on prescribing patterns of antihypertensives in geriatric patients. Perspect Clin Res. 2012;3:139-142.
13.
SreedharanNRaoPGMRauNRShankarPR.Antihypertensive prescribing preferences in three South Indian Hospitals: cost analysis, physicians perspectives and emerging trends. Int J Clin Pharmacol Ther. 2011;49:277-285.
14.
RachanaPAnuradhaH.Anti hypertensive prescribing patterns and cost analysis for primary hypertension: a retrospective study. J Clin Diagn Res. 2014;8:19-22.
15.
MankadavathAChandrasekharDThomasTZuhraFKaipanthodiSParambilJC.A prospective drug use evaluation of antihypertensive drugs in in-patients of a tertiary referral care hospital. J Basic Clin Physiol Pharmacol. 2015;26:295-300.
16.
TandonVRSharmaSMahajanS, et al. Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women. J Midlife Health. 2014;5:78-83.
17.
ParadkarSGSinhaSR.Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: a cross-sectional study. Clin Exp Hypertens. 2018;40:150-154.
18.
AdakePBhatNPNayakRPHafisTBhagyashreeARajPV.Study on prescribing pattern of antihypertensive drugs in a tertiary care hospital. Adv Pharmacol Pharm. 2017;5:21-24.
19.
ReddyPKumarRSwathiD.Current trend in prescribing pattern of antihypertensive drugs in a tertiary care teaching hospital: a prospective observational study. Indo Am J Pharm Sci. 2018;5:1603-1610.
20.
MbuiJMOlukaMNGuantaiEM, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol. 2017;10:1263-1271.
21.
BajraktariGSylejmaniXThaçiKEleziSNdrepepaG.The quality of arterial hypertension treatment in cardiology service in Kosovo—a single center study. Anadolu Kardiy Derg. 2009;9:96-101.
22.
ThinyaneKHMothebeTSooroMNamoleLDCooperV.An observational study of hypertension treatment and patient outcomes in a primary care setting. Pan Afr Med J. 2015;20: 424-434.
23.
YusuffKBBalogunOB.Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. Pharmacoepidemiol Drug Saf. 2005;14:69-74.
24.
EshietUIYusuffKB.Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm. Pharm Pract (Granada). 2014;12:419-425.
25.
OjjiDBAjayiSOMamvenMHAlfaJAlbertinoD.Pattern of prescription of anti-hypertensive medications in a tertiary health care facility in Abuja, Nigeria. Ethn Dis. 2013;23:480-483.
26.
OlanrewajuTAderibigbeABusariOSanyaE.Antihypertensive drug utilization and conformity to guidelines in a sub-Saharan African hypertensive population. Int J Clin Pharmacol Ther. 2010;48:68-75.
27.
BakareOAkinyinkaMGoodmanO, et al. Antihypertensive use, prescription patterns, and cost of medications in a teaching hospital in Lagos, Nigeria. Niger J Clin Pract. 2016;19:668-672.
28.
AdejumoOOkakaEIyaweI.Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria. Malawi Med J. 2017;29:113-117.
29.
AdamuUGAbdulahiAIbrahimFKIbokIO. Pattern of Medication Use among Hypertensives Attending a Specialist Outpatients Clinic in North-Central Nigeria [published online ahead of print]. J Pharm Res Int. Published June 14, 2017. https://doi.org/10.9734/JPRI/2017/33841.
30.
JafarTHJessaniSJafaryFH, et al. General practitioners’ approach to hypertension in urban Pakistan: disturbing trends in practice. Circulation. 2005;111:1278-1283.
31.
HussainIMNaqviBSQasimRMAliN.Current trends in treatment of hypertension in Karachi and cost minimization possibilities. Pak J Med Sci. 2015;31:1021-1026.
KalaiselvanVThotaPSinghGN.Pharmacovigilance programme of India: recent developments and future perspectives. Indian J Pharmacol. 2016;48:624-628.
34.
VedanthanRBernabe-OrtizAHerasmeOI, et al. Innovative approaches to hypertension control in low-and middle-income countries. Cardiol Clin. 2017;35:99-115.
35.
RoushGCSicaDA.Diuretics for hypertension: a review and update. Am J Hypertens. 2016;29:1130-1137.
36.
UbelPAJepsonCAschDA.Misperceptions about β-blockers and diuretics: a national survey of primary care physicians. J Gen Intern Med. 2003;18:977-983.
37.
AhnSYGuptaC.Genetic programming of hypertension. Front Pediatr. 2018;5:285-295.
38.
TongSFKhooEMNordinS, et al. Process of care and prescribing practices for hypertension in public and private primary care clinics in Malaysia. Asia Pac J Public Health. 2012;24:764-775.
39.
AleOKBraimohRW.Hypertension treatment by primary care physicians in Lagos. Niger J Cardiol. 2017;14:19-25.
40.
CastilloRRMercado-AsisLB.Preventing a hypertension “storm surge” in Southeast Asia. Hypertension. 2019;5:40-42.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
